134 related articles for article (PubMed ID: 2895309)
21. Reducing cardiac deaths with hypolipidemic drugs.
Naito HK
Postgrad Med; 1987 Nov; 82(6):102-12. PubMed ID: 3313343
[No Abstract] [Full Text] [Related]
22. Treatment of type III hyperlipoproteinemia with gemfibrozil to retard progression of coronary artery disease.
Kuo PT; Wilson AC; Kostis JB; Moreyra AB; Dodge HT
Am Heart J; 1988 Jul; 116(1 Pt 1):85-90. PubMed ID: 3164977
[TBL] [Abstract][Full Text] [Related]
23. Lessons from the Helsinki Heart Study. Fibric acid therapy for dyslipidemia.
Grundy SM
Postgrad Med; 1988 Jul; 84(1):217-8, 223-31. PubMed ID: 3164473
[No Abstract] [Full Text] [Related]
24. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
Vega GL; Grundy SM
JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
[TBL] [Abstract][Full Text] [Related]
25. Medical management of hyperlipidemia and the role of probucol.
Davignon J
Am J Cardiol; 1986 Jun; 57(16):22H-28H. PubMed ID: 3460320
[TBL] [Abstract][Full Text] [Related]
26. Change in composition of high density lipoprotein during gemfibrozil therapy.
Sorisky A; Ooi TC; Simo IE; Meuffels M; Hindmarsh JT; Nair R
Atherosclerosis; 1987 Oct; 67(2-3):181-9. PubMed ID: 3118893
[TBL] [Abstract][Full Text] [Related]
27. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
Jackson JM; Lee HA
Atherosclerosis; 1984; 51(2-3):189-97. PubMed ID: 6743378
[TBL] [Abstract][Full Text] [Related]
28. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
[TBL] [Abstract][Full Text] [Related]
29. A comparison of different formulations and dosage administrations of gemfibrozil.
Kovanen PT; Koskinen P; Manninen V
Am J Cardiol; 1986 May; 57(14):31G-34G. PubMed ID: 3459351
[TBL] [Abstract][Full Text] [Related]
30. Gemfibrozil for hyperlipidemia.
Med Lett Drugs Ther; 1982 Jun; 24(612):59-60. PubMed ID: 6953310
[No Abstract] [Full Text] [Related]
31. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia.
Lehtonen A; Viikari J
Artery; 1982; 10(5):353-67. PubMed ID: 7181678
[TBL] [Abstract][Full Text] [Related]
32. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
Schwandt P; Richter WO; Weisweiler P; Neureuther G
Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
[TBL] [Abstract][Full Text] [Related]
33. Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia.
Series JJ; Gaw A; Kilday C; Bedford DK; Lorimer AR; Packard CJ; Shepherd J
Br J Clin Pharmacol; 1990 Jul; 30(1):49-54. PubMed ID: 2390432
[TBL] [Abstract][Full Text] [Related]
34. Gemfibrozil therapy in patients with coronary heart disease.
Bell H; Dittmeier G; Martinez L
Mo Med; 1988 Jan; 85(1):27-30. PubMed ID: 3277032
[No Abstract] [Full Text] [Related]
35. Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia.
Lewis JE
Angiology; 1982 Sep; 33(9):603-12. PubMed ID: 6957156
[TBL] [Abstract][Full Text] [Related]
36. Influence of gemfibrozil on high-density lipoproteins.
Glueck C
Am J Cardiol; 1983 Aug; 52(4):31B-34B. PubMed ID: 6577782
[TBL] [Abstract][Full Text] [Related]
37. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788
[TBL] [Abstract][Full Text] [Related]
38. The diagnosis and management of hyperlipidemia.
Gotto AM; Jones PH; Scott LW
Dis Mon; 1986 May; 32(5):245-311. PubMed ID: 3519132
[No Abstract] [Full Text] [Related]
39. Effects of gemfibrozil on serum lipids.
Samuel P
Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843
[TBL] [Abstract][Full Text] [Related]
40. Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition.
Angelin B; Eriksson M; Einarsson K
Eur J Clin Invest; 1986 Oct; 16(5):391-6. PubMed ID: 3100307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
